Oral esketamine for treatment-resistant depression: rationale and design of a randomized controlled trial

Lithium continuation therapy following ketamine in patients with treatment resistant unipolar depression: a randomized controlled trial

(2019) Sara Costi et al.   NEUROPSYCHOPHARMACOLOGY

The Effect of a Single Dose of Intravenous Ketamine on Suicidal Ideation: A Systematic Review and Individual Participant Data Meta-Analysis

(2018) Samuel T. Wilkinson et al.   AMERICAN JOURNAL OF PSYCHIATRY

AMPA Receptor Activation–Independent Antidepressant Actions of Ketamine Metabolite ( S )-Norketamine

(2018) Chun Yang et al.   BIOLOGICAL PSYCHIATRY

Concurrent use of ketamine and monoamine oxidase inhibitors in the treatment of depression: A letter to the editor

(2018) R.B. Katz et al.   GENERAL HOSPITAL PSYCHIATRY

Does oral administration of ketamine accelerate response to treatment in major depressive disorder? Results of a double-blind controlled trial

(2018) Somaye Arabzadeh et al.   JOURNAL OF AFFECTIVE DISORDERS

Ketamine for Depression, 6: Effects on Suicidal Ideation and Possible Use as Crisis Intervention in Patients at Suicide Risk

(2018) Chittaranjan Andrade   JOURNAL OF CLINICAL PSYCHIATRY

Safety and efficacy of maintenance ketamine treatment in patients with treatment-refractory generalised anxiety and social anxiety disorders

(2018) Paul Glue et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Efficacy and Safety of Intranasal Esketamine Adjunctive to Oral Antidepressant Therapy in Treatment-Resistant Depression

(2018) Ella J. Daly et al.   JAMA Psychiatry

Repeated oral ketamine for out-patient treatment of resistant depression: randomised, double-blind, placebo-controlled, proof-of-concept study

(2018) Yoav Domany et al.   BRITISH JOURNAL OF PSYCHIATRY

Predicting Responses to Psychedelics: A Prospective Study

(2018) Eline C. H. M. Haijen et al.   Frontiers in Pharmacology

The Questionnaire for Psychotic Experiences: An Examination of the Validity and Reliability

(2018) Susan L Rossell et al.   SCHIZOPHRENIA BULLETIN

Update of the Dutch manual for costing studies in health care

(2017) Tim A. Kanters et al.   PLoS One

Cognitive Behavior Therapy May Sustain Antidepressant Effects of Intravenous Ketamine in Treatment-Resistant Depression

(2017) Samuel T. Wilkinson et al.   PSYCHOTHERAPY AND PSYCHOSOMATICS

Ketamine augmentation for outpatients with treatment-resistant depression: Preliminary evidence for two-step intravenous dose escalation

(2016) Cristina Cusin et al.   AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY

Intravenous Esketamine in Adult Treatment-Resistant Depression: A Double-Blind, Double-Randomization, Placebo-Controlled Study

(2016) Jaskaran B. Singh et al.   BIOLOGICAL PSYCHIATRY

Oral ketamine for the treatment of pain and treatment-resistant depression

(2016) Robert A. Schoevers et al.   BRITISH JOURNAL OF PSYCHIATRY

New Pharmacological Agents to Aid Smoking Cessation and Tobacco Harm Reduction: What Has Been Investigated, and What Is in the Pipeline?

(2016) Emma Beard et al.   CNS DRUGS

The Dutch Measure for quantification of Treatment Resistance in Depression (DM-TRD): an extension of the Maudsley Staging Method

(2016) Frenk P.M.L. Peeters et al.   JOURNAL OF AFFECTIVE DISORDERS

Efficacy and safety of oral ketamine versus diclofenac to alleviate mild to moderate depression in chronic pain patients: A double-blind, randomized, controlled trial

(2016) Morteza Jafarinia et al.   JOURNAL OF AFFECTIVE DISORDERS

Continuation phase intravenous ketamine in adults with treatment-resistant depression

(2016) Jennifer L. Vande Voort et al.   JOURNAL OF AFFECTIVE DISORDERS

Single-dose infusion ketamine and non-ketamine N-methyl-d-aspartate receptor antagonists for unipolar and bipolar depression: a meta-analysis of efficacy, safety and time trajectories

(2016) T. Kishimoto et al.   PSYCHOLOGICAL MEDICINE

Dutch Tariff for the Five-Level Version of EQ-5D

(2016) Matthijs M. Versteegh et al.   VALUE IN HEALTH

Clinical staging of ketamine-associated urinary dysfunction: a strategy for assessment and treatment

(2016) Peng Wu et al.   WORLD JOURNAL OF UROLOGY

Biomarker approaches in major depressive disorder evaluated in the context of current hypotheses

(2015) Mike C Jentsch et al.   Biomarkers in Medicine

Population pharmacokinetics of S-ketamine and norketamine in healthy volunteers after intravenous and oral dosing

(2015) Samuel Fanta et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Effects of Low-Dose and Very Low-Dose Ketamine among Patients with Major Depression: a Systematic Review and Meta-Analysis

(2015) Ying Xu et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

The anxiodepressive comorbidity in chronic pain

(2014) Ipek Yalcin et al.   Current Opinion in Anesthesiology

A Review of the Clinical, Economic, and Societal Burden of Treatment-Resistant Depression: 1996–2013

(2014) David A. Mrazek et al.   PSYCHIATRIC SERVICES

Feasibility, reliability and validity of a questionnaire on healthcare consumption and productivity loss in patients with a psychiatric disorder (TiC-P)

(2013) Clazien Bouwmans et al.   BMC HEALTH SERVICES RESEARCH

Daily Oral Ketamine for the Treatment of Depression and Anxiety in Patients Receiving Hospice Care: A 28-Day Open-Label Proof-of-Concept Trial

(2013) Scott A. Irwin et al.   JOURNAL OF PALLIATIVE MEDICINE

Treatment-Resistant Depression Increases Health Costs and Resource Utilization

(2013) Beatrice Alinka Lepine et al.   REVISTA BRASILEIRA DE PSIQUIATRIA

Burden of Depressive Disorders by Country, Sex, Age, and Year: Findings from the Global Burden of Disease Study 2010

(2013) Alize J. Ferrari et al.   PLOS MEDICINE

Ketamine for Depression: Where Do We Go from Here?

(2012) Marije aan het Rot et al.   BIOLOGICAL PSYCHIATRY

Prediction of longer-term outcome of treatment-resistant depression in tertiary care

(2012) Abebaw Fekadu et al.   BRITISH JOURNAL OF PSYCHIATRY

Sub-anesthetic concentrations of (R,S)-ketamine metabolites inhibit acetylcholine-evoked currents in α7 nicotinic acetylcholine receptors

(2012) Ruin Moaddel et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Course of Improvement in Depressive Symptoms to a Single Intravenous Infusion of Ketamine vs Add-on Riluzole: Results from a 4-Week, Double-Blind, Placebo-Controlled Study

(2012) Lobna Ibrahim et al.   NEUROPSYCHOPHARMACOLOGY

Ketamine use: a review

(2011) Celia J. A. Morgan et al.   ADDICTION

Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)

(2011) M. Herdman et al.   QUALITY OF LIFE RESEARCH

Reconsidering anhedonia in depression: Lessons from translational neuroscience

(2010) Michael T. Treadway et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

Consequences of chronic ketamine self-administration upon neurocognitive function and psychological wellbeing: a 1-year longitudinal study

(2009) Celia J. A. Morgan et al.   ADDICTION

Treatment-Resistant Depression and Mortality After Acute Coronary Syndrome

(2009) Robert M. Carney et al.   AMERICAN JOURNAL OF PSYCHIATRY

Safety and Efficacy of Repeated-Dose Intravenous Ketamine for Treatment-Resistant Depression

(2009) Marije aan het Rot et al.   BIOLOGICAL PSYCHIATRY

Pharmacological Aspects and Potential New Clinical Applications of Ketamine: Reevaluation of an Old Drug

(2009) Filippia Aroni et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Oral Administration of the NMDA Receptor Antagonist S-Ketamine as Add-On Therapy of Depression: A Case Series

(2009) G. Paslakis et al.   PHARMACOPSYCHIATRY

Nonresponse, partial response, and failure to achieve remission: humanistic and cost burden in major depressive disorder

(2008) Josephine A. Mauskopf et al.   DEPRESSION AND ANXIETY

Comparison of racemic ketamine andS-ketamine in treatment-resistant major depression: Report of two cases

(2008) Robert Paul et al.   WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY